Alkanolaminoxy derivatives of 3,4-dihydro-2H-1,4-benzothiazin-3-one, their production process, and their pharmaceutical use
申请人:MEDIOLANUM FARMACEUTICI s.r.l.
公开号:EP0106816A2
公开(公告)日:1984-04-25
Object of the invention is a class of new organic compounds derived from 1,4-benzothiazine through substitution of an hydrogen atom in position 6, 7 or 8 by an oxypropanolammine radical monosubstituted in N and furthermore a series of new phenyl derivatives of 1,4-benzothiazine, obtained as intermediate in the synthesis of oxypropanolammine derivatives, and process for obtained the new compounds in form suitable for the preparation of pharmaceutical compositions having antihypertensive, vasodilating and antiarrhythmic activity.
本发明的目的是一类新的有机化合物,由 1,4-苯并噻嗪通过 6、7 或 8 位上的氢原子被 N 单取代的氧丙醇胺基所取代而得到,此外还有一系列新的 1,4-苯并噻嗪苯基衍生物,这些衍生物在合成氧丙醇胺衍生物的过程中作为中间体而得到,以及获得这些新化合物的工艺,这些新化合物的形式适合于制备具有抗高血压、血管扩张和抗心律失常活性的药物组合物。